Invention Grant
- Patent Title: Difluoropyrrolidines as orexin receptor modulators
-
Application No.: US15503131Application Date: 2015-08-13
-
Publication No.: US10221170B2Publication Date: 2019-03-05
- Inventor: Theodore M. Kamenecka , Yuanjun He
- Applicant: Eolas Therapeutics, Inc.
- Applicant Address: US CA Carlsbad
- Assignee: Eolas Therapeutics, Inc.
- Current Assignee: Eolas Therapeutics, Inc.
- Current Assignee Address: US CA Carlsbad
- Agency: White & Case LLP
- International Application: PCT/US2015/044974 WO 20150813
- International Announcement: WO2016/025669 WO 20160218
- Main IPC: C07D417/14
- IPC: C07D417/14 ; C07D401/14 ; C07D403/14

Abstract:
The present application relates to certain difluoropyrrolidine compounds, pharmaceutical compositions containing them, and methods of using them, including methods for treating substance addiction, panic disorder, anxiety, post-traumatic stress disorder, pain, depression, seasonal affective disorder, an eating disorder, or hypertension.
Public/Granted literature
- US20170226103A1 DIFLUOROPYRROLIDINES AS OREXIN RECEPTOR MODULATORS Public/Granted day:2017-08-10
Information query